Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effect of Sacubitril/Valsartan Versus Ramipril on Left Ventricular Function and Remodeling in Patients With Ischemic Heart Failure With Mid-range Ejection Fraction

NCT05508035 is registered in ClinicalTrials.gov with John Paul II Hospital, Krakow as lead sponsor.

NCT NCT05508035
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05508035 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effect of Sacubitril/Valsartan Versus Ramipril on Left Ventricular Function and Remodeling in Patients With Ischemic Heart Failure With Mid-range Ejection Fraction
Lead sponsor
John Paul II Hospital, Krakow
Phase
Phase 3
Overall status
Recruiting
Start date
July 13, 2023
Completion date
December 31, 2028
Enrollment
488 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

heart failure with moderately reduced ejection fraction